Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.645 USD | +3.46% | -10.60% | -31.17% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.17% | 65.9M | |
+41.14% | 54.04B | |
+43.57% | 41.96B | |
-1.23% | 41.92B | |
-7.59% | 28.35B | |
+12.42% | 26.35B | |
-22.19% | 19B | |
+7.67% | 13B | |
+28.84% | 12.28B | |
+24.68% | 12.19B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- Evercore ISI Cuts Price Target on Rallybio to $15 From $18, Maintains Outperform Rating